United States: FDA Started A Process To "Downclassify" Most High-Risk IVD Types: Here Is Why - Arnold & Porter

On January 31, the U.S. Food and Drug Administration announced that the Center for Devices and Radiological Health intends to begin the reclassification process for most in vitro diagnostics that are Class III into Class II.